Browse studies

Find your next paid study

91 recruiting studies matching your filters

An Open-Label Phase 1/2a Clinical Trial to Evaluate the Safety, Immunogenicity, and Preliminary Efficacy of a Lentiviral Vector-Based Therapeutic Vaccine Against Human Papilloma Virus (Lenti-HPV-07) in Participants With HPV-Associated Oropharyngeal Squamous Cell Cancer or Cervical Cancer

The goal of this clinical trial is to learn about the safety and efficacy of a potential new treatment called Lenti-HPV-07 in patients with a cancer induced by…

Estimated

~$10 – $8,750

Theravectys S.A.NCT06319963

Phase 3

COVE-4: A Phase 3, Open-Label, Long-Term Follow-Up Study to Evaluate the Safety and Efficacy of YCANTH (VP-102/TO-208) in Subjects With Common Warts (Verruca Vulgaris)

People who participated in either the COVE-2 or COVE-3 study for common warts, may be eligible to enroll into this Long Term Follow Up (LTFU) study COVE-4. The…

Common Warts (Verruca Vulgaris)Common WartsHuman Papilloma Virus (HPV)+1 more

Estimated

~$10 – $8,750

Verrica Pharmaceuticals Inc.NCT07457918

Observational

Culturally Targeted Messaging and Parental Receptivity to the Human Papillomavirus Vaccine

The goal of this clinical trial is to learn if culturally targeted messaging about the human papillomavirus (HPV) increases receptivity to the HPV vaccine amon…

HPV Vaccination

Estimated

~$10 – $6,250

Michigan State UniversityNCT07301905

Phase 2

A Phase II Study of Sacituzumab Govitecan in Combination With Cetuximab in Patients With Recurrent Metastatic HNSCC That Has Progressed After First-Line Therapy

The purpose of this study to find out whether sacituzumab govitecan in combination with cetuximab is an effective and safe treatment approach for people with r…

Squamous Cell Carcinoma of Head and NeckSinus CancerNasal Cavity Cancer+9 more

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT07063212

Observational

Advancing Cervical Cancer Screening Through Emergency Department-based Self-Sampling

This project will compare the uptake of cervical cancer screening through ED HPV sampling among patients presenting to the ED.

HPVHPV Associated CancersHPV Cancers+2 more

Estimated

~$10 – $6,250

University of RochesterNCT07345897

Phase 2

Neoadjuvant Chemotherapy and PD-1 Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

The NeoScorch HN study is a single institution multisite phase II trial including 3 cohorts of 25 patients each for patients with newly diagnosed locoregionall…

Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+6 more

Estimated

~$10 – $6,250

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07209189

Phase 2

A Phase II Study of Volrustomig, Paclitaxel, and Carboplatin Followed by Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer

The purpose of this study is to assess the objective response rate following neoadjuvant therapy with volrustomig, paclitaxel, and carboplatin in previously un…

Head and Neck CancerHPV

Estimated

~$10 – $6,250

University of ChicagoNCT07065630